Lantern Pharma

www.lanternpharma.com

AI-driven oncology drug development. Lantern's RADR platform identifies patient subsets and biomarkers for in-licensed oncology assets.

Visit Website Drug Discovery & Pharma

Overview

AI-driven oncology drug development.

Details

Lantern’s RADR platform identifies patient subsets and biomarkers for in-licensed oncology assets.

Tags

drug-discovery oncology biomarkers public-company

Back to AI Healthcare Tools

Turn AI reports into shareable sites

Publish reports & dashboards as websites

Make AI-generated reports public, stable, and easy to update — free to start.

Try Revdoku →